Delta-Fly Pharma (TSE:4598) Other Current Liabilities: 円1.86 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4598 Delta-Fly Pharma Inc TSE:4598
30 GF Score
Price 円104.00
! 2 Warning Signs
View Full Analysis

What is Delta-Fly Pharma Other Current Liabilities?

Delta-Fly Pharma TSE:4598 -0.95% 30 Other Current Liabilities is 円1.86 Mil as of Mar. 2026. GuruFocus rates TSE:4598 with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Delta-Fly Pharma's other current liabilities for the quarter that ended in Mar. 2026 was 円1.86 Mil.

Delta-Fly Pharma's quarterly other current liabilities increased from Sep. 2025 (円1.87 Mil) to Dec. 2025 (円2.09 Mil) but then declined from Dec. 2025 (円2.09 Mil) to Mar. 2026 (円1.86 Mil).

Delta-Fly Pharma's annual other current liabilities declined from Mar. 2024 (円3.30 Mil) to Mar. 2025 (円1.88 Mil) and declined from Mar. 2025 (円1.88 Mil) to Mar. 2026 (円1.86 Mil).

Delta-Fly Pharma Other Current Liabilities Related Terms

Delta-Fly Pharma Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Delta-Fly Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delta-Fly Pharma Other Current Liabilities Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.96 2.05 3.30 1.88 1.86

Delta-Fly Pharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.88 2.15 1.87 2.09 1.86
TSE:4598
30GF Score
Delta-Fly Pharma Inc TSE:4598
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Delta-Fly Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円1.86 Mil mean?
Delta-Fly Pharma (TSE:4598) has a Other Current Liabilities of 円1.86 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Delta-Fly Pharma.
Is Delta-Fly Pharma's Other Current Liabilities too high?
Delta-Fly Pharma's current Other Current Liabilities is 円1.86 Mil. Overall, Delta-Fly Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Delta-Fly Pharma's Other Current Liabilities compare to VRTX and REGN?
Delta-Fly Pharma's Other Current Liabilities of 円1.86 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Delta-Fly Pharma. Delta-Fly Pharma's current Other Current Liabilities is 円1.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delta-Fly Pharma stock overvalued right now?
Delta-Fly Pharma (TSE:4598) has a current Other Current Liabilities of 円1.86 Mil. The current Other Current Liabilities is 円1.86 Mil. Delta-Fly Pharma's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Delta-Fly Pharma (TSE:4598), the current Other Current Liabilities is 円1.86 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delta-Fly Pharma Business Description

Address 37-5, Miyajima Nishikino, Kawauchi-cho, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
30GF Score

Get the complete analysis for TSE:4598

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円104.00
Price